Volume 13, Number 1—January 2007
Research
Multidrug-resistant Acinetobacter Infection Mortality Rate and Length of Hospitalization
Rebecca H. Sunenshine*, Marc-Oliver Wright†, Lisa L. Maragakis‡, Anthony D. Harris†, Xiaoyan Song‡, Joan Hebden†, Sara E. Cosgrove‡, Ashley Anderson*, Jennifer Carnell*, Daniel B. Jernigan*, David G. Kleinbaum*, Trish M. Perl‡, Harold C. Standiford†, and Arjun Srinivasan*
Table 3
Multivariable analysis of outcomes of patients with and without multidrug-resistant (MDR) Acinetobacter infections, Baltimore hospitals, 2003–2004*
| Outcome evaluated | MDR Acinetobacter vs. susceptible† OR (95% CI) | MDR Acinetobacter vs. uninfected† OR (95% CI) |
|---|---|---|
| Length of stay, d | 2.5 (1.2–5.2) | 2.5 (1.2–5.4) |
| Intensive care unit length of stay, d | 2.1 (1.0–4.3) | 4.2 (1.5–11.6) |
| Mortality rate (%) | 2.6 (0.3–26.1) | 6.6 (0.4–108.3) |
*OR, odds ratio; CI, confidence interval.
†Models include modified Acute Physiology and Chronic Health Evaluation III score to control for severity of illness and Charlson index to control for underlying disease.
